Increasing resilience of medical supply chains during the COVID-19 pandemic
Why building future resilience requires a delicate balance between increased flexibility, efficiency and welfare advantages of GVCs.
Your browser may not be supported by this website. Please upgrade to the latest version provided by your browser vendor.
Why building future resilience requires a delicate balance between increased flexibility, efficiency and welfare advantages of GVCs.
The recovery of supply chains can be supported through trade policies and firm-specific initiatives.
COVID-19 struck at the core of GVC hub regions, with severe implications for international production networks.